Study of the pharmacological activity of a supplement based on ginsenoside of 6-year-old ginseng root against the infectious bronchitis virus of chickens

The infectious bronchitis viruses of chickens and SARS-CoV-2 are similar, therefore, the mechanism of entry of the IBD virus into the lungs through the intestine is considered as a simulation of the entry of the SARS-CoV-2 virus into the body. To conduct a laboratory experiment on the study of infectious bronchitis in chickens, Beaver cross chickens at the age of 14 days were inoculated with a 10-fold dose of the vaccine strain of infectious bronchitis in chickens. In this study, experimental birds were divided into one infected control group and two experimental groups (to evaluate the preventive and curative effectiveness of the supplement). The most pronounced pathoanatomic changes were noted in the group in which the drug was administered to the bird for therapeutic purposes. In the experimental group, in which the drug was administered before the introduction of an infectious agent (for preventive purposes), inflammatory processes were less pronounced, which may indicate the preventive effectiveness of the drug. When studying the number of viral particles, it was revealed that there was no suppression of the virus in the thymus of birds receiving the supplement for therapeutic purposes, as a result of which systemic circulation of viral particles throughout the body was observed. In the group receiving the drug for preventive purposes, through the use of a dietary supplement, the effect of the viral agent on the thymus was prevented until the virus entered the body, thereby ensuring a smoother course of coronavirus infection. An increase in the expression of proinflammatory cytokines was noted in both experimental groups. It has been established that the use of biologically active food additives “Gold of the Emperor. Immunity” causes activation of NFkB production in the thymus, lungs and intestines when the drug is used for therapeutic purposes. Application of biologically active additive “Gold of the Emperor. Immunity” caused a more intensive production of proinflammatory cytokines, however, in the case of its use for the purpose of pharmacoprophylaxis, the body’s reaction from the immune system, the course of coronavirus infection was the most favorable for the body as a whole.

1. Borisov A.V., Borisov V.V., Farm Animals, 2014, No. 5, pp. 72–74. (In Russ.)

2. Borisov A.V., Klyuchevsky V.V., Irza V.N., BIO, 2018, No. 211, pp. 35–38. (In Russ.)

3. Mironova T.E. i dr., Veterinariya i kormlenie, 2020, No. 7, pp. 35–38. (In Russ.)

4. Nefedova E. et al., The infectious bronchitis coronavirus pneumonia model presenting a novel insight for the SARSCoV-2 dissemination route, Veterinary Sciences, 2021, Vol. 8, No. 10, pp. 239.

5. Afonyushkin V.N., BIO, 2020, No. 4, pp. 4–6. (In Russ.)

6. Cavanagh D., Coronaviruses in poultry and other birds, Avian Pathol, 2005, No. 34, pp. 439–448.

7. Callison S.A., Hilt D.A, Boynton T.O. et al., Development and evaluation of a real-time Taqman RT-PCR assay for the detection of infectious bronchitis virus from infected chickens, J Virol Methods, 2006, Vol. 138, pp. 60–65, DOI: 10.1016/j.jviromet.2006.07.018.

8. Fabricant J., The early history of infectious bronchitis, Avian Dis, 1998, Vol. 42, pp. 648–650.

9. Fisinin V.I., Suraj P.N., Sel’skohozyajstvennaya biologiya, 2013, No. 4, pp. 3–17. (In Russ.)

10. Qi F. et al., Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses, Biochemical and biophysical research communications, 2020, Vol. 526, No. 1, pp. 135–140.

11. Proekt Atlasa chelovecheskogo belka, finansiruemyj Fondom Knuta i Alisy Vallenberg. URL: https://www.proteinatlas.org/ENSG00000130234-ACE2. (In Russ.)

12. Lamers M.M. et al., SARS-CoV-2 productively infects human gut enterocytes, Science, 2020, Vol. 369, No. 6499, pp. 50–54.

13. Ferreira A.C. et al., SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes, Cell death discovery, 2021, Vol. 7, No. 1, pp. 43.

14. Vora S.M., Lieberman J., Wu H., Inflammasome activation at the crux of severe COVID-19, Nature Reviews Immunology, 2021, Vol. 21, No. 11, pp. 694–703.

15. Junqueira C. et al., SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release, Research square, 2021, DOI: 10.21203/rs.3rs-153628/v1.

16. Shimabukuro-Vornhagen A. et al., Cytokine release syndrome, Journal for immunotherapy of cancer, 2018, Vol. 6, No. 1, pp. 1–14.

17. Freeman T.L., Swartz T.H., Targeting the NLRP3 inflammasome in severe COVID-19, Frontiers in immunology, 2020, Vol. 11, pp. 1518, DOI: 10.3389/fimmu.2020.01518.

18. Godeau D. et al., Return-to-work, disabilities and occupational health in the age of COVID-19, Scandinavian journal of work, environment & health, 2021, Vol. 47, No. 5, pp. 408.

19. Merad M., Martin J.C., Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages, Nature reviews immunology, 2020, Vol. 20, No. 6, pp. 355–362.

20. Ahn M. et al., Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host, Nature microbiology, 2019, Vol. 4, No. 5, pp. 789–799.

21. Jung E.M., Lee G.S., Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic, Journal of Ginseng Research, 2022, Vol. 46, No. 3, pp. 331–336.

22. Anugrah R., Mumtaz R.K., Suryasaputra D., Study In-Silico Oleanane Triterpenoids in Aquilaria spp. as a Covid-19 Antiviral, IOP Conference Series: Earth and Environmental Science, IOP Publishing, 2022, Vol. 1104, No. 1, pp. 012027.

23. Lunicyn V.G., Volodkina A.I., Sibirskij vestnik sel’skohozyajstvennoj nauki, 2007, No. 10 (178), pp. 45–49. (In Russ.)

24. Mihajlov N.O. i dr., Mnogoprofil’nyj stacionar, 2019, Vol. 6, No. 1, pp. 85–7. (In Russ.)

25. Bahadori B. et al., ω‐3 Fatty Acids Infusions as Adjuvant Therapy in Rheumatoid Arthritis, Journal of Parenteral and Enteral Nutrition, 2010, Vol. 34, No. 2, pp. 151–155.

26. Calder P.C., Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale, Biochimie, 2009, Vol. 91, No. 6, pp. 791–795.

27. Vengerovskij A.I. i dr., Protivovospalitel’noe i anal’geticheskoe dejstvie polyarnyh lipidov pantov marala i torfa pri eksperimental’nom vospalenii, Byulleten’ sibirskoj mediciny, 2012, Vol. 11, No. 6, pp. 31–35. (In Russ.)

28. Duthie G., Crozier A., Plant-derived phenolic antioxidants, Current opinion in lipidology, 2000, Vol. 11, No. 1, pp. 43–47.

29. Vereshchagina S.V. i dr., Sovremennye voprosy biomediciny, 2021, Vol. 5, No. 4 (17), pp. 10–18. (In Russ.)

30. Shahagadkar P. et al., Berry derived constituents in suppressing viral infection: Potential avenues for viral pandemic management, Clinical Nutrition ESPEN, 2021, Vol. 46, pp. 14–20.

31. Bormann M. et al., Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro, Viruses, 2021, Vol. 13, No. 10, pp. 1914.

32. Gombart A.F., Pierre A., Maggini S., A review of micronutrients and the immune system–working in harmony to reduce the risk of infection, Nutrients, 2020, Vol. 12, No. 1, pp. 236.

33. Deng Y. et al., Association of fat-soluble vitamins (A, D, and E) status with humoral immune response to COVID-19 inactivated vaccination, Frontiers in Nutrition, 2023, Vol. 10, pp. 1167920.

34. Samad N. et al., Fat-soluble vitamins and the current global pandemic of COVID-19: Evidence-based efficacy from literature review, Journal of inflammation research, 2021, Vol. 14, pp. 2091.

35. Bobikova A.S., CHerepushkina V.S., Mironova T.E., Afonyushkin V.N., Donchenko N.A., Nefedova E.V., Fudi YA., Koptev V.YU., Fomenko V.V., Sibirskij vestnik sel’skohozyajstvennoj nauki, 2021, No. 51 (5), pp. 68–76, DOI: 10.26898/0370-8799-2021-5-8. (In Russ.)

36. Cheng P. et al., Baicalin alleviates lipopolysaccharide-induced liver inflammation in chicken by suppressing TLR4- mediated NF-κB pathway, Frontiers in pharmacology, 2017, Vol. 8, pp. 547, URL: https://www.frontiersin.org/articles/10.3389/fphar.2017.00547/full.

37. Sun X. et al., Analysis of chicken macrophage functions and gene expressions following infectious bronchitis virus M41 infection, Veterinary research, 2021, Vol. 52, No. 1, pp. 1–15, URL: https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-021-00896-z.

38. Afonyushkin V.N., Bobikova A.S., Mironova T.E., CHerepushkina V.S., SHtepa V.N., Veterinariya i kormlenie, 2022, No. 2, pp. 11–16, DOI: 10.30917/ATT-VK-1814-9588-2022-2-3. (In Russ.)

39. Choi Y.D., Xin Z.C., Choi H.K, Effect of Korean red ginseng on the rabbit corpus cavernosal smooth muscle, Int J Impot Res, 1998, Vol. 10, pp. 37–43.

40. Xi Q.Y., Jiang Y., Zhao S., Zeng B., Wang F., Wang L.N., Jiang Q.Y., Zhang Y.L., Effect of ginseng polysaccharides on the immunity and growth of piglets by dietary supplementation during late pregnancy and lactating sows, Anim Sci J, 2017, No. 88, pp. 863–872.

41. Lee Y.S., Chung I.S., Lee I.R., Kim K.H., Hong W.S., Yun Y.S., Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccha-ride ginsan isolated from Panax ginseng, Anticancer Res, 1997, No. 17, pp. 323–331.

42. Ilsley S.E., Miller H.M., Kamel C., Effects of dietary quillaja saponin and curcumin on the performance and immune status of weanling piglets, J Anim Sci, 2005, No. 83, pp. 82–88.

43. Ao X., Meng Q.W., Kim I.H., Effects of fermented red ginseng supplementation on growth performance, apparent nutrient digestibility, blood hematology and meat quality in finishing pigs, Asian Austral J Anim Sci, 2011, Vol. 24, pp. 525–531.

44. Lee S.I., Kim J.K., Hancock J.D., Kim I.H., β-glucan from mulberry leaves and curcuma can improve growth performance and nutrient digestibility in early weaned pigs, J Appl Anim Res, 2016, Vol. 45, pp. 209–214.